Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
D05WPQ
|
||||
Former ID |
DNC000364
|
||||
Drug Name |
BW A4C
|
||||
Drug Type |
Small molecular drug
|
||||
Indication | Arthritis [ICD9: 710-719; ICD10:M00-M25] | Terminated | [544587] | ||
Structure |
Download2D MOL |
||||
Formula |
C17H17NO3
|
||||
Canonical SMILES |
CC(=O)N(CC=CC1=CC(=CC=C1)OC2=CC=CC=C2)O
|
||||
InChI |
1S/C17H17NO3/c1-14(19)18(20)12-6-8-15-7-5-11-17(13-15)21-16-9-3-2-4-10-16/h2-11,13,20H,12H2,1H3/b8-6+
|
||||
InChIKey |
CEUDWZXMLMKPNN-SOFGYWHQSA-N
|
||||
CAS Number |
CAS 106328-57-8
|
||||
PubChem Compound ID | |||||
PubChem Substance ID | |||||
Target and Pathway | |||||
Target(s) | Arachidonate 5-lipoxygenase | Target Info | Inhibitor | [536189], [536518], [537431] | |
NetPath Pathway | IL4 Signaling Pathway | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
References | |||||
Ref 536189 | Tumour necrosis factor production in a rat airpouch model of inflammation: role of eicosanoids. Agents Actions. 1991 Mar;32(3-4):289-94. | ||||
Ref 536518 | Hydroxamic acids and hydroxyureas as novel, selective 5-lipoxygenase inhibitors for possible use in asthma. Agents Actions Suppl. 1991;34:189-99. | ||||
Ref 537431 | Reactive oxygen species and lipoxygenases regulate the oncogenicity of NPM-ALK-positive anaplastic large cell lymphomas. Oncogene. 2009 Jul 23;28(29):2690-6. Epub 2009 Jun 8. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.